Drug–Drug Conjugates as Intelligent Preclinical Platforms for Targeted Cancer Therapy
Drug–drug conjugates (DDCs), in which two active pharmaceutical ingredients (APIs) are linked covalently within a single molecular structure to produce a synergistic therapeutic effect, represent an emerging category of single-molecule therapeutics. These conjugates differ from conventional combination therapies by uti...